Biotech · Private company
BioNTech Research & Development, Inc.
Track this companyFree. Adds BioNTech Research & Development, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- gemcitabine + nab-paclitaxelPhase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- modified FOLFIRINOX (mFOLFIRINOX)Phase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- MVT-1075Phase 1 · Pancreatic CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- MVT-2163Phase 1 · Pancreatic CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- MVT-5873Phase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- MVT-5873Phase 1 · Pancreatic CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as RadioimmunotherapyPHASE1 · TERMINATED · started Jun 1, 2017ClinicalTrials.gov NCT03118349 · fetched Nov 12, 2026
- Phase 1 Imaging Study of 89Zr-DFO-HuMab-5B1 With HuMab-5B1PHASE1 · TERMINATED · started Jul 11, 2016ClinicalTrials.gov NCT02687230 · fetched Nov 12, 2026
- Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive MalignanciesPHASE1 · TERMINATED · started Jan 1, 2016ClinicalTrials.gov NCT02672917 · fetched Nov 12, 2026